Skip to main content

European Vascular Interventions and Therapeutic Innovation Network

Objective

EVOluTION, a pioneering network within EU in view of its focus on endogenous protective mechanisms, is formed to provide training for 11 young researchers in innovative therapeutic strategies, integrating early detection and prevention, to yield novel approaches to the management of chronic vascular and metabolic diseases that affect the increasing ageing population of Western societies. Fully aligned with the knowledge triangle (business, research and higher education) platform being developed at the EU level, EVOluTION-trained young scientists will gain valuable knowledge and multidisciplinary skills: only interdisciplinary and cross-cutting research can lead to novel therapeutic tools and scientific angles to address these challenging medical, societal and industrial issues.
EVOluTION provides a conducive structure by bringing 5 leading academic institutions and 1 SME, together with 6 Pharma and biotech companies, 1 Policy-maker, and 1 Patent & Trade firm as Partner Organisations, from 6 EU countries.
The science of EVOluTION evolves around the innovative concept of boosting natural protective mechanisms operating in our body, focusing on the vasculature, to answer 3 key questions: Can we exploit mediators and targets of endogenous tissue protection? Can we exploit these pathways to yield innovative therapeutic strategies? Can dietary approaches boost these endogenous protective processes? The Network Partners guarantee delivery of training through knowledge creation, knowledge exploitation and knowledge communication. Scientific and educational expertise of the partners, leaders in areas like computational chemistry, nutraceuticals, resolution pharmacology and vascular therapies will be maximally exploited. The EVOluTION training platform is based on state-of-the-art lab-based and network-wide and local training activities, including secondments and scientific visits and specialized transferable skills focussed in entrepreneurship and societal engagement.

Field of science

  • /medical and health sciences/basic medicine/pharmacology and pharmacy
  • /medical and health sciences/basic medicine/neurology/stroke
  • /medical and health sciences/clinical medicine/endocrinology/diabetes/diabetic nephropathy
  • /medical and health sciences/clinical medicine/nephrology/kidney diseases
  • /medical and health sciences/clinical medicine/cardiology/cardiovascular diseases/arteriosclerosis
  • /natural sciences/biological sciences/biochemistry/biomolecules/lipids

Call for proposal

H2020-MSCA-ITN-2015
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

QUEEN MARY UNIVERSITY OF LONDON
Address
327 Mile End Road
E1 4NS London
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 819 863,64

Participants (5)

UNIVERSITEIT MAASTRICHT
Netherlands
EU contribution
€ 766 122,84
Address
Minderbroedersberg 4-6
6200 MD Maastricht
Activity type
Higher or Secondary Education Establishments
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Ireland
EU contribution
€ 265 674,60
Address
Belfield
4 Dublin
Activity type
Higher or Secondary Education Establishments
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 498 432,96
Address
Geschwister Scholl Platz 1
80539 Muenchen
Activity type
Higher or Secondary Education Establishments
KAROLINSKA INSTITUTET
Sweden
EU contribution
€ 263 659,32
Address
Nobels Vag 5
17177 Stockholm
Activity type
Higher or Secondary Education Establishments
LIFEARC
United Kingdom
EU contribution
€ 273 287,88
Address
7Th Floor Lynton House 7-12 Tavistock Square
WC1H 9LT London
Activity type
Research Organisations

Partners (7)

THE ROYAL SOCIETY OF CHEMISTRY
United Kingdom
Address
Milton Road - Thomas Graham House - Science Park
CB4 0WF Cambridge
Activity type
Other
QUINTILES LIMITED
United Kingdom
Address
500 Brook Drive, Green Park, Berkshire
RG2 6UU Reading
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UCB PHARMA SA
Belgium
Address
Allee De La Recherche 60
1070 Bruxelles
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Genomics England Limited
United Kingdom
Address
4Th Floor Skipton House 80 London Road
London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MosaMedix
Netherlands
Address
Oude Rijksweg Zuid 21
6114 RC Susteren
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kilburn & Strode
United Kingdom
Address

London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
William Harvey Research Limited
United Kingdom
Address

London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)